Skip to main content
Clinical Trials/CTRI/2023/11/060169
CTRI/2023/11/060169RecruitingPhase 4

Comparison of phenytoin aand leveteracitam for prophylaxis of seizures in the early postoperative period in TBI patients-a pilot study

Hospital supplyfree of cost Sherikashmir institute of medical sciences1 site in 1 country30 target enrollmentStarted: November 30, 2023Last updated:

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
1)Time to first seizure

Study Overview

Brief Summary

Traumatic brain injury is one of the leading causes of death and disability through out the world .Occurance of seizures can worsen the outcome in these patients. Though TBI guidelines advocate the use of phenytoin for early onset seizures in TBI, there is emerging evidence that the use of the broad spectrum drugs as leveteracitam may be helpful in ameliorating the seizures in the early postoperative period .This pilot study is being done to compare phenytoin with levetiracetam for prophylaxis of seizures in TBI patients.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 95.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Pts 18yrs or above 2)Pts with diagnosis of TBI 3)GCS less than 8.

Exclusion Criteria

  • Pts with history of epilepsy or seizure disorder.
  • Pt with history of hypersensitivity or allergy to phenytoin or leviteracetam.
  • Pt with history of liver or kidney disease.
  • Pts who are pregnant or breast feeding.
  • Pts who don’t give consent.

Outcomes

Primary Outcomes

1)Time to first seizure

Time Frame: During 7 days

2)total seizures during 7 days

Time Frame: During 7 days

Secondary Outcomes

  • No. of days of icu stay.(No. of days of hospital stay)

Investigators

Sponsor
Hospital supplyfree of cost Sherikashmir institute of medical sciences
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials